20th Jan 2015 09:49
LONDON (Alliance News) - Advanced Oncotherapy PLC on Tuesday said it has created an external CERN Scientific Review Board which will provide the company with guidance as its develops and commercialises its LIGHT proton therapy system.
The board will be chaired by Stephen Myers, Head of CERN Medical Applications and the former Director of Accelerators and Technology at CERN. Sanjeev Pandya, Chief Executive of Advanced Oncotherapy, will also sit on the board.
"Advanced Oncotherapy's collaboration with CERN is our flagship venture. The advice we will receive from this newly formed committee will give us the opportunity to develop and commercialise, within our stated timeline, our ground-breaking proton therapy system; technology that we believe will offer clinical advantages at significantly less capital outlay than machines powered by cyclotrons and synchrotrons," said Pandya.
Shares in Advanced Oncotherapy were down 0.7% to 3.898 pence on Tuesday.
By Sam Unsted; [email protected]; @SamUAtAlliance
Copyright 2015 Alliance News Limited. All Rights Reserved.
Related Shares:
AVO.L